NovaBone Products launches a first foot and ankle-specific
syringe delivery system for its bioactive glass delivery
system.
ALACHUA,
Fla., Sept. 18, 2023 /PRNewswire-PRWeb/ --
NovaBone Products, leader in synthetic biologics, is pleased to
announce the company has made commercially available a new syringe
for targeted delivery of its 45S5 bioactive glass putty device for
the foot and ankle market. The newly launched syringe comes in both
a 2.5cc and a 5cc formulation.
"We are excited to provide our foot and ankle surgeons with a
specific solution to deliver our best-in-class synthetic putty to
their patients. This is NovaBone's first product specifically
designed for the foot and ankle market. Along with our NovaForm
Wound Matrix clearance earlier this year, this shows our commitment
to diversifying our portfolio, leveraging our Bioactive Glass
manufacturing expertise, and providing surgeons in multiple
specialties with solutions best suited for their patients." said
Sean Finnerty, Executive Vice
President of Sales and Marketing at NovaBone.
NovaBone's Putty, cleared by the FDA in 2006, is a highly
effective bone graft substitute that closely mimics the mineral
composition of natural bone. NovaBone provides an ideal environment
for new bone formation, facilitating the integration of graft
material and host tissue.
The foot and ankle syringe is commercially available in the US
Market. Dr. Charles E. Cook of Dallas, Texas, was the first foot and ankle
surgeon to use the new product designed for medical use of
bioactive glass.
"I had the opportunity to use the new 2.5cc syringe delivery
system in the OR today. The putty met all my needs and
expectations. The putty flowed nicely into the osseous defect, and
the putty's viscosity provided a nice tapenade effect,
providing hemostasis. I have been using the larger volume delivery
system of NovaBone putty in my practice with great success, and
these smaller delivery systems are a much-needed addition for
diverse applications."
For more information on the new bioactive glass syringe,
contact us today by visiting our website, novabone.com.
About NovaBone
NovaBone, a Halma company, is privately held and based in
Florida since 2002. NovaBone
developed the first bioactive glass for bone healing offered to the
orthopedic community and has long been at the forefront of
bioactive glass bone graft devices. It has developed numerous
formulations and delivery systems of its patented, bioactive glass
technology platform that results in accelerated bone growth. In
total, their exclusively formulated bone graft substitute has been
used for the repair of osseous defects throughout the skeletal
system for over a decade and used in over a million clinical
applications with unparalleled success, validating the safety and
efficacy of NovaBone's technology.
Media Contact
Sean P. Finnerty, NovaBone
Products, 1 908 432 3353, sfinnerty@novabone.com,
www.novabone.com
View original content to download
multimedia:https://www.prweb.com/releases/novabones-new-bioactive-glass-syringe-for-foot--ankle-301930912.html
SOURCE NovaBone Products